Live feed08:00:00·454dPRReleasevia QuantisnowIMUNON Finalizes Phase 3 Study Design with FDA for IMNN-001 in Newly Diagnosed Advanced Ovarian CancerByQuantisnow·Wall Street's wire, on your screen.IMNN· Imunon Inc.Health Care
